In the evolving landscape of diabetes management, novel medications like semaglutide and retatrutide are gaining traction. These compounds, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, https://esmeemyno187177.blogoscience.com/45664131/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management